M&A Deal Summary

Enzo Acquires Assay Designs

On March 26, 2009, Enzo acquired life science company Assay Designs from Ampersand Capital Partners for 12M USD

Acquisition Highlights
  • This is Enzo’s 1st transaction in the Life Science sector.
  • This is Enzo’s 2nd largest (disclosed) transaction.
  • This is Enzo’s 2nd transaction in the United States.
  • This is Enzo’s 1st transaction in Michigan.

M&A Deal Summary
Date 2009-03-26
Target Assay Designs
Sector Life Science
Buyer(s) Enzo
Sellers(s) Ampersand Capital Partners
Deal Type Add-on Acquisition
Deal Value 12M USD
Advisor(s) BroadOak Capital Partners (Financial)

Target

Assay Designs

Ann Arbor, Michigan, United States
Assay Designs, Inc. sells worldwide a steadily expanding research product line that includes kits and reagents for the detection and quantification of small molecules and proteins that are important in inflammation and immunity, oxidative and cellular stress, steroid and hormone biology, cell signaling, and bioenergetics.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Enzo

Farmingdale, New York, United States
Category Company
Founded 1976
Sector Life Science
Employees179
Revenue 31M USD (2023)
DESCRIPTION

Enzo is a life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. Enzo was incorporated in 1976 and is based in Farmingdale, New York.

DEAL STATS #
Overall 2 of 2
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 2 of 2
State (Michigan) 1 of 1
Country (United States) 2 of 2
Year (2009) 1 of 1
Size (of disclosed) 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-05-09 BIOMOL International

Plymouth Meeting, Pennsylvania, United States

BIOMOL International, LP is a privately owned global producer of over 3,300 specialty life science products for the areas of signal transduction, lipid research, apoptosis, neuroscience and drug discovery, with a research focus in the field of functional proteomics.

Buy $18M

Seller(S) 1

SELLER

Ampersand Capital Partners

Wellesley, Massachusetts, United States

Investor Investor Investor Investor Investor

Category Growth Capital Firm
Founded 1988
PE ASSETS 2.0B USD
Size Large
Type Sector Focused
DESCRIPTION

Ampersand Capital Partners is a middle-market private equity group that concentrates on growth equity investment opportunities in the healthcare sector. The Firm looks to invest $10 to $100 million in businesses with $10 to $100 million of revenue. Specific areas of interests within healthcare include lab products, specialty diagnostic equipment, pharmaceutical outsourcing, and specialty pharma. Ampersand generally prefers to be the first and sole institutional investor. Ampersand was formed in 1988 and is based in Wellesley, Massachusetts.

DEAL STATS #
Overall 10 of 55
Sector (Life Science) 3 of 25
Type (Add-on Acquisition) 7 of 38
State (Michigan) 1 of 1
Country (United States) 10 of 51
Year (2009) 2 of 2
Size (of disclosed) 13 of 13
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2009-03-09 Ortho Organizers

Carlsbad, California, United States

Ortho Organizers is a full-line manufacturer and distributor of orthodontics products.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2009-10-26 Roadrunner Pharmacy

Phoenix, Arizona, United States

Roadrunner Pharmacy, Inc. is a provider of technology-enabled healthcare services for companion and equine veterinary practitioners. Roadrunner Pharmacy, Inc. was established in 1999 and is based in Phoenix, Arizona.

Buy -
Mergr

Product

Company

Legal